US-based small molecule medicines provider Innoviva (formerly Advanced Medicine) has announced a private placement of convertible senior notes due 2025 to raise $175m.

Biotechnology company Seattle Genetics plans to acquire biopharmaceutical firm Bristol-Myers Squibb’s pharmaceutical manufacturing facility located in Bothell, Washington, US.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

“Biotechnology company Seattle Genetics plans to acquire biopharmaceutical firm Bristol-Myers Squibb’s pharmaceutical manufacturing facility located in Bothell, Washington, US.”

The acquisition will help the company to expand its antibody drug conjugate and immuno-oncology pipeline.

PlasmaGen BioSciences Private has secured $25m through a venture financing round led by Eight Roads Ventures India.

The Indian biopharmaceutical company will use the funds for the expansion of its product portfolio.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now